iNtRON Biotechnology Inc (048530) — Cash Flow Quality Index
iNtRON Biotechnology Inc (048530) has a Cash Flow Quality Index of -4.73x as of June 2024. Operating cash flow of ₩-2.74 Billion is below net income of ₩579.25 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 048530 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
iNtRON Biotechnology Inc Cash Flow Quality Index (2015–2022)
Historical Cash Flow Quality Index for iNtRON Biotechnology Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see iNtRON Biotechnology Inc cash conversion from operations.
Annual Cash Flow Quality Index for iNtRON Biotechnology Inc (2015–2022)
Year-by-year earnings quality comparison for iNtRON Biotechnology Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.05x | ₩5.98 Billion | ₩5.71 Billion | ▼ -38.2% |
| 2021 | 1.69x | ₩16.47 Billion | ₩9.73 Billion | ▲ +255.0% |
| 2020 | 0.48x | ₩7.13 Billion | ₩14.95 Billion | ▼ -1.1% |
| 2018 | 0.48x | ₩4.20 Billion | ₩8.71 Billion | ▼ -55.8% |
| 2015 | 1.09x | ₩1.70 Billion | ₩1.56 Billion | — |